Современная фармакотерапия гастроэзофагеальной рефлюксной болезни

Abstract

On the basis of the positive dynamics of the disease clinical picture, endoscopic changes of the distal areas of the esophagus and the decrease of the esophagus oxydation time during the whole day time till the physiological norms a high effectiveness of Lanzoprasole (Lanzap) and Cyzapride (Peristil) in patients with gastroesophageal reflux disease (military man and civil ones) of stages II-III was established. The indication of Lanzoprasole administration for patients with gastroesophageal reflux disease is in the considerably increased acid forming function of the stomach and the prolonged time of the esophagus oxydation during the day, the indication of Cyzapride is in the insufficiency of lower esophageal sphyncter. Military service patients should be administered supporting dosages of Lanzap and Peristil in minimal dose during 3 months after that the question of the treatment continuation necessity is to be solved.